Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamita B Shah

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Reviews in Gastroenterological Disorders|January 25, 2008
Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautionsShamita B Shah, Stephen B Hanauer
Reviews in Gastroenterological Disorders|October 30, 2008
Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel diseaseShamita B Shah, Stephen B Hanauer
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 4, 2026
Expanding access and comprehensive care in the management of patients with inflammatory bowel disease with pharmacy servicesShamita B Shah, Estela Lajthia, Sheena Babin, et al.
Digestive Diseases and Sciences|April 30, 2010
Incidence and risk of intestinal and extra-intestinal complications in Medicaid patients with inflammatory bowel disease: a 5-year population-based studyGaurav Arora, Gurkirpal Singh, Shweta Vadhavkar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2015
Prevalence of Anal Dysplasia in Patients With Inflammatory Bowel DiseaseShamita B Shah, Danielle Pickham, Hiwot Araya, et al.
Scientific Reports|April 28, 2021
Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapyHarrison M Penrose, Rida Iftikhar, Morgan E Collins, et al.
Scandinavian Journal of Gastroenterology|July 8, 2020
Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitisAhmad Hassan Ali, Jennifer Damman, Shamita B Shah, et al.
Expert Review of Gastroenterology & Hepatology|February 20, 2026
Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease - paving a path forwardJohn Grady, Kevin M Johnson, Richard Kellermayer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Reviews in Gastroenterological Disorders|January 25, 2008
Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautionsShamita B Shah, Stephen B Hanauer
Reviews in Gastroenterological Disorders|October 30, 2008
Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel diseaseShamita B Shah, Stephen B Hanauer
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 4, 2026
Expanding access and comprehensive care in the management of patients with inflammatory bowel disease with pharmacy servicesShamita B Shah, Estela Lajthia, Sheena Babin, et al.
Digestive Diseases and Sciences|April 30, 2010
Incidence and risk of intestinal and extra-intestinal complications in Medicaid patients with inflammatory bowel disease: a 5-year population-based studyGaurav Arora, Gurkirpal Singh, Shweta Vadhavkar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2015
Prevalence of Anal Dysplasia in Patients With Inflammatory Bowel DiseaseShamita B Shah, Danielle Pickham, Hiwot Araya, et al.
Scientific Reports|April 28, 2021
Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapyHarrison M Penrose, Rida Iftikhar, Morgan E Collins, et al.
Scandinavian Journal of Gastroenterology|July 8, 2020
Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitisAhmad Hassan Ali, Jennifer Damman, Shamita B Shah, et al.
Expert Review of Gastroenterology & Hepatology|February 20, 2026
Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease - paving a path forwardJohn Grady, Kevin M Johnson, Richard Kellermayer, et al.
Pageof 1